Cosmo Pharmaceuticals N.V. (LON:0RGI)
London flag London · Delayed Price · Currency is GBP · Price in CHF
63.60
+2.60 (4.26%)
At close: Jul 24, 2025

Cosmo Pharmaceuticals Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
182.27266.7992.78102.0965.0760.95
Upgrade
182.27266.7992.78102.0965.0760.95
Upgrade
Revenue Growth (YoY)
-1.66%187.55%-9.12%56.88%6.77%-2.47%
Upgrade
Cost of Revenue
47.7845.3639.3440.4932.9827.62
Upgrade
Gross Profit
134.49221.4353.4461.632.133.33
Upgrade
Selling, General & Admin
39.4841.5337.9919.9810.5218.68
Upgrade
Research & Development
33.5434.6819.2515.4611.2913.6
Upgrade
Other Operating Expenses
-7.24-3.66-1.92-1.9-0.82-0.75
Upgrade
Operating Expenses
65.7772.5555.3233.542131.53
Upgrade
Operating Income
68.72148.88-1.8828.0611.11.81
Upgrade
Interest Expense
-0.09-0.05-8.53-9.16-8.99-8.73
Upgrade
Interest & Investment Income
1.421.674.072.943.061.75
Upgrade
Earnings From Equity Investments
----17.75-4.94
Upgrade
Currency Exchange Gain (Loss)
-1.431.02-1.362.762.24-1.49
Upgrade
Other Non Operating Income (Expenses)
-0.07-0.07-0.12-0.11-0.48-0.17
Upgrade
EBT Excluding Unusual Items
68.55151.45-7.8124.4924.68-11.78
Upgrade
Gain (Loss) on Sale of Investments
3.61.921.33-0.02-0.68-0.25
Upgrade
Gain (Loss) on Sale of Assets
-----4
Upgrade
Other Unusual Items
-----1.1
Upgrade
Pretax Income
72.15153.37-6.4924.4724-6.93
Upgrade
Income Tax Expense
12.1720.184.216.972.330.97
Upgrade
Earnings From Continuing Operations
59.98133.19-10.717.5121.67-7.9
Upgrade
Minority Interest in Earnings
0.010.05-0.08-0.28-0-
Upgrade
Net Income
59.99133.24-10.7817.2321.67-7.9
Upgrade
Net Income to Common
59.99133.24-10.7817.2321.67-7.9
Upgrade
Net Income Growth
1.73%---20.52%--
Upgrade
Shares Outstanding (Basic)
161616161714
Upgrade
Shares Outstanding (Diluted)
161616161714
Upgrade
Shares Change (YoY)
1.65%1.94%-1.95%-2.83%16.81%-1.11%
Upgrade
EPS (Basic)
3.688.14-0.671.051.29-0.55
Upgrade
EPS (Diluted)
3.678.12-0.671.051.28-0.55
Upgrade
EPS Growth
0.09%---18.20%--
Upgrade
Free Cash Flow
67.76157.8619.3628.717.128.87
Upgrade
Free Cash Flow Per Share
4.149.621.201.750.420.61
Upgrade
Dividend Per Share
2.0502.0502.0001.0500.950-
Upgrade
Dividend Growth
2.50%2.50%90.48%10.53%--
Upgrade
Gross Margin
73.79%83.00%57.60%60.34%49.32%54.69%
Upgrade
Operating Margin
37.70%55.81%-2.02%27.48%17.06%2.96%
Upgrade
Profit Margin
32.91%49.94%-11.62%16.87%33.30%-12.96%
Upgrade
Free Cash Flow Margin
37.17%59.17%20.87%28.12%10.95%14.54%
Upgrade
EBITDA
80.45160.479.2741.1717.816.06
Upgrade
EBITDA Margin
44.14%60.15%9.99%40.33%27.37%9.94%
Upgrade
D&A For EBITDA
11.7311.5911.1413.116.714.25
Upgrade
EBIT
68.72148.88-1.8828.0611.11.81
Upgrade
EBIT Margin
37.70%55.81%-2.02%27.48%17.06%2.96%
Upgrade
Effective Tax Rate
16.87%13.15%-28.47%9.71%-
Upgrade
Updated Jul 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.